[EN] 1,3,4-OXADIAZOLE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS<br/>[FR] DÉRIVÉS DE 1,3,4-OXADIAZOLE EN TANT QU'INHIBITEURS D'HISTONE DÉSACÉTYLASE
申请人:QUIMATRYX S L
公开号:WO2020212479A1
公开(公告)日:2020-10-22
The present invention refers to oxadiazole compounds of formula (I) suitable as HDAC6 inhibitors. Processes for their preparation and their medical uses in treating HDAC6-related diseases or disorders are also disclosed.
1,3,4-OXADIAZOLE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS
申请人:QUIMATRYX, S.L.
公开号:EP3956324A1
公开(公告)日:2022-02-23
US6586405B2
申请人:——
公开号:US6586405B2
公开(公告)日:2003-07-01
[EN] NON-COVALENT INHIBITORS OF UROKINASE AND BLOOD VESSEL FORMATION<br/>[FR] INHIBITEURS NON COVALENTS DE L'UROKINASE ET DE LA FORMATION DE VAISSEAUX SANGUINS
申请人:CORVAS INT INC
公开号:WO2002014349A2
公开(公告)日:2002-02-21
Novel compounds having activity as non-covalent inhibitors of urokinase and having activity in reducing or inhibiting blood vessel formation are provided. These compounds have P1 a group having an amidino or guanidino moiety or derivative thereof. These compounds are useful in vitro for monitoring plasminogen activator levels and in vivo in treatment of conditions which are ameliorated by inhibition of or decreased activity of urokinase and in treating pathologic conditions wherein blood vessel formation is related to a pathologic condition.